Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy

Neurosurgery

Volumn 68, Issue 5, 2011, Pages 1380-1387

  Miyata, Shiro ^a   Kawabata, Shinji ^a   Hiramatsu, Ryo ^a   Doi, Atsushi ^a   Ikeda, Naokado ^a   Yamashita, Taro ^a   Kuroiwa, Toshihiko ^a   Kasaoka, Satoshi ^b   Maruyama, Kazuo ^c   Miyatake, Shin Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Boron neutron capture therapy; Computed tomography; Convection enhanced delivery; Liposome; Transferrin

Indexed keywords

BOROCAPTATE; BORON 10; IOMEPROL; MACROGOL; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BRAIN TISSUE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENCAPSULATION; GLIOMA; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; THERMODYNAMICS; TUMOR CELL CULTURE;

ANIMALS; BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; GLIOMA; IODINE; IOPAMIDOL; LIPOSOMES; MALE; RATS; RATS, INBRED F344; SULFHYDRYL COMPOUNDS; TOMOGRAPHY, X-RAY COMPUTED; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 79955037020     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820b52aa     Document Type: Article

References (22)

1. Miyatake S, Kawabata S, Nonoguchi N, et al. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas. Neuro Oncol. 2009;11(4):430-436.
2. Miyatake S, Kawabata S, Yokoyama K, et al. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas. JNeurooncol. 2009;91(2):199-206.
3. Miyatake S, Kawabata S, Kajimoto Y, et al. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. JNeurosurg. 2005;103(6):1000-1009. (Pubitemid 43194548)
4. Kawabata S, Miyatake S, Kajimoto Y, et al. The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report oftwo cases. JNeurooncol. 2003;65(2):159-165. (Pubitemid 37521315)
5. Kawabata S, Miyatake S, Kuroiwa T, et al. Boron neutron capture therapy for newly diagnosed glioblastoma. JRadiat Res (Tokyo). 2009;50(1):51-60.
6. Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status andfuture prospects. Clin Cancer Res. 2005;11(11):3987-4002. (Pubitemid 40791562)
7. Wei Q, Kullberg EB, Gedda L. Trastuzumab-conjugated boron-containing lip-osomes for tumor-cell targeting; development and cellular studies. Int J Oncol. 2003;23(4):1159-1165.
8. Yang W, Barth RF, Adams DM, et al. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting ofEGF receptor-positive gliomas. Cancer Res. 2002;62(22):6552-6558. (Pubitemid 35364121)
9. Doi A, Kawabata S, Iida K, et al. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. JNeurooncol. 2008;87(3):287-294.
10. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA. 1994;91(6):2076-2080. (Pubitemid 24092045)
11. Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means ofcetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther. 2006;5(1):52-59.
12. Mukundan S Jr, Ghaghada KB, Badea CT, et al. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006;186(2):300-307. (Pubitemid 46100296)
13. Saito R, Bringas JR, McKnight TR, et al. Distribution ofliposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res. 2004;64(7):2572-2579. (Pubitemid 38523915)
14. Dickinson PJ, LeCouteur RA, Higgins RJ, et al. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. J Neurosurg. 2008;108(5):989-998. (Pubitemid 351656848)
15. Aoki I, Bakalova R MR molecular imaging using drug delivery system. Drug Delivery System. 2008;23(1):61-68.
16. Weaver M, Laske DW. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol. 2003;65(1):3-13. (Pubitemid 37441310)
17. Murad GJ, Walbridge S, Morrison PF, et al. Real-time, image-guided, convection-enhanced delivery ofinterleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res. 2006;12(10):3145-3151. (Pubitemid 43837363)
18. Vogelbaum MA. Convection enhanced delivery for the treatment of malignant gliomas: symposium review. JNeurooncol. 2005;73(1):57-69. (Pubitemid 40823269)
19. Rousseau J, Boudou C, Esteve F, Elleaume H. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(3):943-951. (Pubitemid 46818758)
20. Maruyama K, Ishida O, Kasaoka S, et al. Intracellular targeting of sodium mer-captoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).J Control Release. 2004;98(2):195-207. (Pubitemid 38950731)
21. Lonser RR, Walbridge S, Garmestani K, et al. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. JNeurosurg. 2002;97(4):905-913. (Pubitemid 35222414)
22. Rainov NG, Soling A. Clinical studies with targeted toxins in malignant glioma. Rev Recent Clin Trials. 2006;1(2):119-131.